Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: Investigating the Use of Genetics to Guide Pharmacologic Therapy for Hypertension [Phase 2]
Phase 2 clinical trial exploring pharmacogenomics-guided therapy for hypertension.
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: Nicotinamide Mononucleotide in Hypertensive Patients [Phase 4]
Phase 4 trial update for nicotinamide mononucleotide in hypertensive patients; current status is unknown.
-
FDA approval · 2022-01-31FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva's IRBESARTAN AND HYDROCHLOROTHIAZIDE, establishing approval of the generic combination prod…
-
FDA approval · 2022-01-27FDA Approved: NEBIVOLOL — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Nebivolol filed by ANI Pharmaceuticals, Inc. for Nebivolol product.
-
FDA approval · 2022-01-27FDA Approved: FUROSEMIDE — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved an original generic application for furosemide from Meitheal Pharmaceuticals Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-01-26FDA Approved: NEBIVOLOL — Supplemental Application (AvKARE)
FDA approved a supplemental application for Nebivolol Hydrochloride by AvKARE, indicating an additional approval related to the generic prod…
-
FDA approval · 2022-01-26FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Original Application (GLENMARK PHARMACEUTICALS INC., USA)
FDA approved an original application for a generic fixed-dose combination drug of bisoprolol fumarate and hydrochlorothiazide for hypertensi…
-
FDA approval · 2022-01-24FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (AvKARE)
FDA approved a supplemental application for a generic combination tablet of telmisartan and hydrochlorothiazide manufactured by AvKARE.
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: Vascular Dysfunction in Hypertensive Postmenopausal Women [Phase 4]
Phase 4 trial investigating vascular dysfunction in hypertensive postmenopausal women has been terminated; results posted.
-
FDA approval · 2022-01-14FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for losartan potassium and hydrochlorothiazide from Alembic Pharmaceuticals Limited, signifying an a…
-
FDA approval · 2022-01-14FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for a generic Telmisartan and Hydrochlorothiazide combination from Alembic Pharmaceuticals Limit…
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: Renal Denervation in Patients With Uncontrolled Blood Pressure [NA]
Clinical trial update for renal denervation in patients with uncontrolled blood pressure; study terminated with results posted.
-
FDA label_change · 2022-01-12FDA Approved: TOPROL XL — Supplemental Application (Melinta Therapeutics, LLC)
FDA approved a supplemental application for TOPROL XL (metoprolol succinate) to update the labeling, submitted by Melinta Therapeutics, LLC.
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia [Phase 3]
A Phase 3 clinical trial completed evaluating the efficacy and safety of a fixed-dose olmesartan/amlodipine/rosuvastatin combination for pat…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Pharmacy Home Adherence Reporting and Monitoring Outcomes Study [NA]
A completed clinical trial examining pharmacy home adherence reporting and monitoring outcomes for patients with diabetes and hypertension (…
-
CLINICAL_TRIALS trial_result · 2022-01-10Clinical Trial Update: Evaluation of Immunogenicity and Safety of COVID-19 Vaccine (Produced in Beijing) in Patients With Hypertension and/or Diabetes [Phase 4]
Phase 4 trial update evaluating immunogenicity and safety of a Beijing-produced COVID-19 vaccine in patients with hypertension and/or diabet…
-
FDA approval · 2021-12-23FDA Approved: LISINOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for lisinopril submitted by Camber Pharmaceuticals, Inc., approving changes to the lisinopril pr…
-
FDA approval · 2021-12-23FDA Approved: PRAZOSIN HYDROCHLORIDE — Original Application (Exelan Pharmaceuticals)
FDA approved the original ANDA for prazosin hydrochloride (generic) manufactured by Exelan Pharmaceuticals.
-
FDA approval · 2021-12-20FDA Approved: IRBESARTAN — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for Irbesartan from Aurobindo Pharma Limited.
-
FDA approval · 2021-12-20FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
The FDA approved a supplemental application for Hospira's verapamil hydrochloride under an existing approved product, marking an update to t…
-
FDA approval · 2021-12-20FDA Approved: IRBESARTAN — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for IRBESARTAN from Unichem Pharmaceuticals (USA), Inc. for this generic product (ANDA 203020).
-
FDA approval · 2021-12-17FDA Approved: NEBIVOLOL — Original Application (Modavar Pharmaceuticals LLC)
FDA approved the original abbreviated new drug application for Nebivolol by Modavar Pharmaceuticals LLC, establishing a generic version of n…
-
FDA approval · 2021-12-17FDA Approved: NEBIVOLOL — Original Application (Aurobindo Pharma Limited)
FDA approved Nebivolol via an original Abbreviated New Drug Application by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: Walking Exercise on Memory, Subjective Cognitive Complaint, and Brain-derived Neurotrophic Factor for Hypertension [NA]
A completed clinical trial evaluating walking exercise effects on memory, subjective cognitive complaints, and brain-derived neurotrophic fa…
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: S-Metoprolol XR 25-50 mg Tablets vs Metoprolol Zok 50-100 mg Tablets in Hypertension Patients. [Phase 4]
Phase 4 trial comparing S-Metoprolol XR 25-50 mg tablets to Metoprolol Zok 50-100 mg tablets in hypertension patients.